BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

88 related articles for article (PubMed ID: 38608280)

  • 21. A Splicing Transcriptome-Wide Association Study Identifies Candidate Altered Splicing for Prostate Cancer Risk.
    Sun Y; Bae YE; Zhu J; Zhang Z; Zhong H; Cheng C; Deng Y; Wu C; Wu L
    OMICS; 2023 Aug; 27(8):372-380. PubMed ID: 37486714
    [TBL] [Abstract][Full Text] [Related]  

  • 22. A splicing transcriptome-wide association study identifies novel altered splicing for Alzheimer's disease susceptibility.
    Sun Y; Bae YE; Zhu J; Zhang Z; Zhong H; Yu J; Wu C; Wu L
    Neurobiol Dis; 2023 Aug; 184():106209. PubMed ID: 37354922
    [TBL] [Abstract][Full Text] [Related]  

  • 23. B4GALT1 promotes immune escape by regulating the expression of PD-L1 at multiple levels in lung adenocarcinoma.
    Cui Y; Li J; Zhang P; Yin D; Wang Z; Dai J; Wang W; Zhang E; Guo R
    J Exp Clin Cancer Res; 2023 Jun; 42(1):146. PubMed ID: 37303063
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Associations between genetically predicted levels of blood metabolites and pancreatic cancer risk.
    Zhong H; Liu S; Zhu J; Wu L
    Int J Cancer; 2023 Jul; 153(1):103-110. PubMed ID: 36757187
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Golgi Phosphoprotein 73: The Driver of Epithelial-Mesenchymal Transition in Cancer.
    Liu Y; Hu X; Liu S; Zhou S; Chen Z; Jin H
    Front Oncol; 2021; 11():783860. PubMed ID: 34950590
    [TBL] [Abstract][Full Text] [Related]  

  • 26. A transcriptome-wide association study identifies novel candidate susceptibility genes for prostate cancer risk.
    Liu D; Zhu J; Zhou D; Nikas EG; Mitanis NT; Sun Y; Wu C; Mancuso N; Cox NJ; Wang L; Freedland SJ; Haiman CA; Gamazon ER; Nikas JB; Wu L
    Int J Cancer; 2022 Jan; 150(1):80-90. PubMed ID: 34520569
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Integrating Genome and Methylome Data to Identify Candidate DNA Methylation Biomarkers for Pancreatic Cancer Risk.
    Zhu J; Yang Y; Kisiel JB; Mahoney DW; Michaud DS; Guo X; Taylor WR; Shu XO; Shu X; Liu D; Li B; Tao R; Cai Q; Zheng W; Long J; Wu L
    Cancer Epidemiol Biomarkers Prev; 2021 Nov; 30(11):2079-2087. PubMed ID: 34497089
    [TBL] [Abstract][Full Text] [Related]  

  • 28. A transcriptome-wide association study of Alzheimer's disease using prediction models of relevant tissues identifies novel candidate susceptibility genes.
    Sun Y; Zhu J; Zhou D; Canchi S; Wu C; Cox NJ; Rissman RA; Gamazon ER; Wu L
    Genome Med; 2021 Sep; 13(1):141. PubMed ID: 34470669
    [TBL] [Abstract][Full Text] [Related]  

  • 29. A transcriptome-wide association study identifies novel blood-based gene biomarker candidates for Alzheimer's disease risk.
    Sun Y; Zhou D; Rahman MR; Zhu J; Ghoneim D; Cox NJ; Beach TG; Wu C; Gamazon ER; Wu L
    Hum Mol Genet; 2021 Dec; 31(2):289-299. PubMed ID: 34387340
    [TBL] [Abstract][Full Text] [Related]  

  • 30. TNF-α induces endothelial-mesenchymal transition promoting stromal development of pancreatic adenocarcinoma.
    Adjuto-Saccone M; Soubeyran P; Garcia J; Audebert S; Camoin L; Rubis M; Roques J; Binétruy B; Iovanna JL; Tournaire R
    Cell Death Dis; 2021 Jun; 12(7):649. PubMed ID: 34172716
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Long non-coding RNA TP73-AS1 promotes pancreatic cancer growth and metastasis through miRNA-128-3p/GOLM1 axis.
    Wang B; Sun X; Huang KJ; Zhou LS; Qiu ZJ
    World J Gastroenterol; 2021 May; 27(17):1993-2014. PubMed ID: 34007135
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Associations between Genetically Predicted Circulating Protein Concentrations and Endometrial Cancer Risk.
    Zhu J; O'Mara TA; Liu D; Setiawan VW; Glubb D; Spurdle AB; Fasching PA; Lambrechts D; Buchanan D; Kho PF; Cook LS; Friedenreich C; Lacey JV; Chen C; Wentzensen N; De Vivo I; Sun Y; Long J; Du M; Shu XO; Zheng W; Wu L; Yu H
    Cancers (Basel); 2021 Apr; 13(9):. PubMed ID: 33925895
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Translational pharmacokinetic-pharmacodynamic modeling of preclinical and clinical data of the oral MET inhibitor tepotinib to determine the recommended phase II dose.
    Xiong W; Friese-Hamim M; Johne A; Stroh C; Klevesath M; Falchook GS; Hong DS; Girard P; El Bawab S
    CPT Pharmacometrics Syst Pharmacol; 2021 May; 10(5):428-440. PubMed ID: 33818908
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Global Cancer Statistics 2020: GLOBOCAN Estimates of Incidence and Mortality Worldwide for 36 Cancers in 185 Countries.
    Sung H; Ferlay J; Siegel RL; Laversanne M; Soerjomataram I; Jemal A; Bray F
    CA Cancer J Clin; 2021 May; 71(3):209-249. PubMed ID: 33538338
    [TBL] [Abstract][Full Text] [Related]  

  • 35. The STRING database in 2021: customizable protein-protein networks, and functional characterization of user-uploaded gene/measurement sets.
    Szklarczyk D; Gable AL; Nastou KC; Lyon D; Kirsch R; Pyysalo S; Doncheva NT; Legeay M; Fang T; Bork P; Jensen LJ; von Mering C
    Nucleic Acids Res; 2021 Jan; 49(D1):D605-D612. PubMed ID: 33237311
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Associations Between Genetically Predicted Protein Levels and COVID-19 Severity.
    Zhu J; Wu C; Wu L
    J Infect Dis; 2021 Jan; 223(1):19-22. PubMed ID: 33083826
    [TBL] [Abstract][Full Text] [Related]  

  • 37. A Transcriptome-Wide Association Study Identifies Candidate Susceptibility Genes for Pancreatic Cancer Risk.
    Liu D; Zhou D; Sun Y; Zhu J; Ghoneim D; Wu C; Yao Q; Gamazon ER; Cox NJ; Wu L
    Cancer Res; 2020 Oct; 80(20):4346-4354. PubMed ID: 32907841
    [TBL] [Abstract][Full Text] [Related]  

  • 38. An integrative multi-omics analysis to identify candidate DNA methylation biomarkers related to prostate cancer risk.
    Wu L; Yang Y; Guo X; Shu XO; Cai Q; Shu X; Li B; Tao R; Wu C; Nikas JB; Sun Y; Zhu J; Roobol MJ; Giles GG; Brenner H; John EM; Clements J; Grindedal EM; Park JY; Stanford JL; Kote-Jarai Z; Haiman CA; Eeles RA; Zheng W; Long J; ; ; ; ;
    Nat Commun; 2020 Aug; 11(1):3905. PubMed ID: 32764609
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Cabozantinib Inhibits Photodynamic Therapy-Induced Auto- and Paracrine MET Signaling in Heterotypic Pancreatic Microtumors.
    Broekgaarden M; Alkhateeb A; Bano S; Bulin AL; Obaid G; Rizvi I; Hasan T
    Cancers (Basel); 2020 May; 12(6):. PubMed ID: 32485915
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Associations between Genetically Predicted Blood Protein Biomarkers and Pancreatic Cancer Risk.
    Zhu J; Shu X; Guo X; Liu D; Bao J; Milne RL; Giles GG; Wu C; Du M; White E; Risch HA; Malats N; Duell EJ; Goodman PJ; Li D; Bracci P; Katzke V; Neale RE; Gallinger S; Van Den Eeden SK; Arslan AA; Canzian F; Kooperberg C; Beane Freeman LE; Scelo G; Visvanathan K; Haiman CA; Le Marchand L; Yu H; Petersen GM; Stolzenberg-Solomon R; Klein AP; Cai Q; Long J; Shu XO; Zheng W; Wu L
    Cancer Epidemiol Biomarkers Prev; 2020 Jul; 29(7):1501-1508. PubMed ID: 32439797
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 5.